Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cardiovascular risk factors disease among non european immigrants living catalonia
… Collaboration Share on: February 5, 2018 The goal of the European Network of Centers for Pharmacoepidemiology and … Before ENCePP, post-authorization studies requested by European regulators were often conducted in the US. ENCePP … Jan 11;2018:1-8. Related Services Pharmacoepidemiology and Risk Management Staff Members Susana Perez-Gutthann Alejandro …
… 17, 2017 Emergence of a new paradigm in understanding the cardiovascular system: pulse synchronized contractions has been published in the Journal of Cardiovascular Pharmacology . 2017;6(5):220. doi: … lead to a new appreciation for the development of certain cardiovascular diseases, and, therefore, potentially inform …
… Using Primary Data Collection To meet the requirements of risk management programs, inform drug development and … studies can help you: Understand the natural history of a disease and its treatment Quantify and characterize product … of patients, physicians, and caregivers Evaluate risk management programs including REMS and EU-RMPs Depending …
… influenza vaccination in patients with end-stage renal disease Layton JB , McGrath LJ, Sahrmann JM, Ma Y, … Plotting daily incidence of influenza vaccine reactions among patients with end-stage renal disease to inform study design decisions Layton JB , …
2023 Italian Society of Hygiene, Preventive Medicine, and Public Health (SITI) Conference Share on: Thursday, October 12 - Saturday, October 14, 2023 Conference website Research coauthored by RTI Health Solutions experts will be presented at the 2023 …
… Infectious Disease Week (IDWeek) 2023 Share on: Wednesday, October 11 - … Prevalence of underlying conditions associated with higher risk for severe RSV, influenza, or COVID-19 in adults in the …
… diseases. Recent project types have included: Benefit-risk preference studies Burden of illness studies Conjoint … models (cost effectiveness, budget impact) Dynamic disease transmission modeling Economic burden of illness … and to support regulatory requirements Linear and non-linear programming studie s to estimate the impact of …
… caused by the screening process, the likelihood of a high-risk cancer, and the health of the patient. To optimize decisions that take those factors into account, the authors developed a partially … medical history to get a better estimate of a patient’s risk for cancer. The authors found that the methods they …
… needs as well as the use of comparative clinical trials, among other factors. How is the Pharmaceutical Industry Responding to … more large-molecule drugs or biologicals instead. On the disease-area level, companies might be thinking of …
… and others conducted a study to evaluate PsA patients’ disease experiences and treatment preferences. Creation of a … the least. Survey participants were also asked which PsA disease impacts were the most and least important to improve. … outcome set and input from clinical experts, a patient living with PsA, and patient advocates. The survey instrument …